BRPI0621489A2 - cepa mutante atenuada de bactéria infectante de espécies veterinárias, vacina para imunização de espécies veterinárias contra uma infecção bacteriana, método para imunizar uma espécie veterinária contra uma infecção bacteriana e uso de uma cepa mutante atenuada - Google Patents

cepa mutante atenuada de bactéria infectante de espécies veterinárias, vacina para imunização de espécies veterinárias contra uma infecção bacteriana, método para imunizar uma espécie veterinária contra uma infecção bacteriana e uso de uma cepa mutante atenuada Download PDF

Info

Publication number
BRPI0621489A2
BRPI0621489A2 BRPI0621489-4A BRPI0621489A BRPI0621489A2 BR PI0621489 A2 BRPI0621489 A2 BR PI0621489A2 BR PI0621489 A BRPI0621489 A BR PI0621489A BR PI0621489 A2 BRPI0621489 A2 BR PI0621489A2
Authority
BR
Brazil
Prior art keywords
mutant strain
strain
vaccine
veterinary
mutant
Prior art date
Application number
BRPI0621489-4A
Other languages
English (en)
Portuguese (pt)
Inventor
Greve Henri Marcel Jozef De
Connie Theresia Adriaensen
Jean-Pierre Ernest Clement Hernalsteens
Original Assignee
Univ Bruxelles
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bruxelles filed Critical Univ Bruxelles
Publication of BRPI0621489A2 publication Critical patent/BRPI0621489A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36Adaptation or attenuation of cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • A61K39/0258Escherichia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • A61K39/0275Salmonella
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BRPI0621489-4A 2006-03-20 2006-03-20 cepa mutante atenuada de bactéria infectante de espécies veterinárias, vacina para imunização de espécies veterinárias contra uma infecção bacteriana, método para imunizar uma espécie veterinária contra uma infecção bacteriana e uso de uma cepa mutante atenuada BRPI0621489A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/BE2006/000019 WO2007106956A1 (en) 2006-03-20 2006-03-20 Live attenuated salmonella vaccine

Publications (1)

Publication Number Publication Date
BRPI0621489A2 true BRPI0621489A2 (pt) 2011-12-13

Family

ID=37430822

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0621489-4A BRPI0621489A2 (pt) 2006-03-20 2006-03-20 cepa mutante atenuada de bactéria infectante de espécies veterinárias, vacina para imunização de espécies veterinárias contra uma infecção bacteriana, método para imunizar uma espécie veterinária contra uma infecção bacteriana e uso de uma cepa mutante atenuada

Country Status (7)

Country Link
EP (1) EP2004802A1 (ja)
JP (1) JP2009529895A (ja)
AU (1) AU2006340699A1 (ja)
BR (1) BRPI0621489A2 (ja)
CA (1) CA2646421A1 (ja)
MX (1) MX2008012056A (ja)
WO (1) WO2007106956A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080260777A1 (en) 2007-04-19 2008-10-23 Sotomayor Konky Composition and method for controlling intestinal pathogenic organisms
US7935355B2 (en) 2007-04-19 2011-05-03 Nutritional Health Institute Laboratories, Llc Composition and method for controlling intestinal pathogenic organisms
WO2010083477A2 (en) * 2009-01-16 2010-07-22 University Of Maryland, Baltimore Broad spectrum vaccine against non-typhoidal salmonella
US9011871B2 (en) 2011-11-07 2015-04-21 University Of Maryland, Baltimore Broad spectrum vaccine against typhoidal and non-typhoidal Salmonella disease
CZ307672B6 (cs) * 2012-05-30 2019-02-13 VÝZKUMNÝ ÚSTAV VETERINÁRNÍHO LÉKAŘSTVÍ, v.v.i. Vakcína pro orální podání hospodářským zvířatům

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6190669B1 (en) * 1998-05-13 2001-02-20 University Of Maryland, Baltimore Attenuated mutants of salmonella which constitutively express the Vi antigen

Also Published As

Publication number Publication date
CA2646421A1 (en) 2007-10-11
AU2006340699A1 (en) 2007-09-27
WO2007106956A1 (en) 2007-09-27
JP2009529895A (ja) 2009-08-27
MX2008012056A (es) 2008-12-18
EP2004802A1 (en) 2008-12-24

Similar Documents

Publication Publication Date Title
US20110052635A1 (en) Live attenuated salmonella vaccine
US7887816B2 (en) Attenuated microorganisms for the treatment of infection
Marc et al. Colonization ability and pathogenic properties of a fim− mutant of an avian strain of Escherichia coli
ES2316492T3 (es) Vacuna contra la salmonella.
US8071356B2 (en) Salmonella enterica strains of reduced pathogenicity, method for their preparation and uses thereof
BRPI0621489A2 (pt) cepa mutante atenuada de bactéria infectante de espécies veterinárias, vacina para imunização de espécies veterinárias contra uma infecção bacteriana, método para imunizar uma espécie veterinária contra uma infecção bacteriana e uso de uma cepa mutante atenuada
US10351606B2 (en) Mutated Salmonella enterica
JP2005519872A (ja) サルモネラ・ワクチン
KR20080110594A (ko) 약독화 살모넬라 생백신
KR20080105099A (ko) 약독화 살모넬라 생백신
US20100260794A1 (en) Live attenuated salmonella vaccine
CN106661544B (zh) 用于牲畜生产系统的疫苗
JP4705573B2 (ja) 弱毒細菌生ワクチン
KR101950931B1 (ko) ptsI 및 crr 유전자 결손된 약독화 살모넬라 타이피뮤리움 균주 및 상기 균주를 이용한 생균 백신 조성물
Pumtang-on Investigation of Campylobacter jejuni and Campylobacter coli colonisation of commercial free-range chickens
ES2358595T3 (es) Vacunas de bacterias vivas atenuadas.
Serological Salmonella enterica A Live
KR20140053475A (ko) rfaH 결손형 살모넬라 티피뮤리움 균주 및 상기 균주를 이용한 식중독 예방 백신 조성물
BRPI1000173A2 (pt) cepa bacteriana modificada e uso da mesma
CZ24177U1 (cs) Vakcína pro orální podání hospodářským zvířatům

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 7A ANUIDADE

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2214 DE 11/06/2013.